Author:
Németi Balázs,Gregus Zoltán
Publisher
Oxford University Press (OUP)
Reference37 articles.
1. Bantia, S., and Kilpatrick, J. M. (2004). Purine nucleoside phosphorylase inhibitors in T-cell malignancies. Curr. Opin. Drug Discov. Devel.7,243–247.
2. Bantia, S., Miller, P. J., Parker, C. D., Ananth, S. L., Horn, L. L., Kilpatrick, J. M., Morris, P. E., Hutchinson, T. S., Montgomery, J. A., and Sandhu, J. S. (2001). Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H) – a novel potent and orally active immunosuppressive agent. Int. Immunopharmacol.1,1199–1210.
3. Bertolero, F., Pozzi, G., Sabbioni, E., and Saffiotti, U. (1987). Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis8,803–808.
4. Brown, R. E., Jarvis, K. L., and Hyland, K. J. (1989). Protein measurement using bicinchoninic acid: Elimination of interfering substances. Anal. Biochem.180,136–139.
5. Bzowska, A., Kulikowska, E., and Shugar, D. (2000). Purine nucleoside phosphorylases: Properties, functions, and clinical aspects. Pharmacol. Ther.88,349–425.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献